First Financial Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-22
Closed -$2.45K – 431
2024
Q3
$2.45K Hold
22
– – ﹤0.01% 395
2024
Q2
$2.35K Hold
22
– – ﹤0.01% 422
2024
Q1
$2.65K Buy
+22
New +$2.69K ﹤0.01% 489
2022
Q2
– Sell
-16
Closed -$2K – 334
2022
Q1
$2K Hold
16
– – ﹤0.01% 335
2021
Q4
$2K Hold
16
– – ﹤0.01% 345
2021
Q3
$2K Hold
16
– – ﹤0.01% 339
2021
Q2
$3K Buy
+16
New +$2.77K ﹤0.01% 343

Other funds holding JAZZ

First Financial Corp's JAZZ Position: Q4 2024 in Review

First Financial Corp sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 22 shares — an estimated $2.45K sold.

First Financial Corp first reported a position in JAZZ in Q2 2021 and held it in 7 quarters. The position peaked at $3K in Q2 2021. 509 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • First Financial Corp reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Financial Corp sold 22 Jazz Pharmaceuticals shares in Q4 2024, an estimated $2.45K.
  • First Financial Corp first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 7 quarters.
  • First Financial Corp's Jazz Pharmaceuticals position peaked at $3K in Q2 2021.
  • 509 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on First Financial Corp's 13F filing for Q4 2024, filed 13 Jan 2025.